ST2 and Galectin-3: Ready for Prime Time?

ST2 and galectin-3 are emerging biomarkers in the field of heart failure and have been extensively studied, and that whether they provide additional prognostic value on top of the clinical models and the gold standard in HF, (NT-pro)BNP. Our aim was to provide a comprehensive review of these emergin...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijers, Wouter C., van der Velde, A. Rogier, de Boer, Rudolf A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Communications and Publications Division (CPD) of the IFCC 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009948/
https://www.ncbi.nlm.nih.gov/pubmed/27683537

Ejemplares similares

Ejemplares similares